21 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Molecular Cancer Biology

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some highly viewed papers on molecular cancer biology that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of related papers and Special Issues that we believe will interest you:
“Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients”
by Nancy Alnassar, Malgorzata Borczyk, Georgia Tsagkogeorga, Michal Korostynski, Namshik Han and Dariusz C. Górecki
Cancers 2023, 15(5), 1378; https://doi.org/10.3390/cancers15051378
Available online: https://www.mdpi.com/2072-6694/15/5/1378
“The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy”
by Katarzyna Starska-Kowarska
Cancers 2023, 15(6), 1642; https://doi.org/10.3390/cancers15061642
Available online: https://www.mdpi.com/2072-6694/15/6/1642
“Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges”
by Lorenzo Guidi, Gloria Pellizzari, Paolo Tarantino, Carmine Valenza and Giuseppe Curigliano
Cancers 2023, 15(4), 1130; https://doi.org/10.3390/cancers15041130
Available online: https://www.mdpi.com/2072-6694/15/4/1130
“Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management”
by Leili Rejali, Romina Seifollahi Asl, Fatemeh Sanjabi, Nayeralsadat Fatemi, Hamid Asadzadeh Aghdaei, Mahsa Saeedi Niasar, Pardis Ketabi Moghadam, Ehsan Nazemalhosseini Mojarad, Enrico Mini and Stefania Nobili
Cancers 2023, 15(10), 2746; https://doi.org/10.3390/cancers15102746
Available online: https://www.mdpi.com/2072-6694/15/10/2746
“The BAFF-APRIL System in Cancer”
by Md Ashik Ullah and Fabienne Mackay
Cancers 2023, 15(6), 1791; https://doi.org/10.3390/cancers15061791
Available online: https://www.mdpi.com/2072-6694/15/6/1791
“Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance”
by Sonia Mazumder, Paul J. Higgins and Rohan Samarakoon
Cancers 2023, 15(4), 1316; https://doi.org/10.3390/cancers15041316
Available online: https://www.mdpi.com/2072-6694/15/4/1316
“Liver Cancers Molecular Biomarkers Predicting Outcome” Edited by Dr. Nima Kokabi Submission deadline: 10 July 2024 |
“Molecular Insights into Drug Resistance in Cancer” Edited by Dr. Yang Yuqi Submission deadline: 30 June 2024 |
![]() |
![]() |
“Exosomes in Tumor” Edited by Dr. Sandra E. Ghayad and Dr. Nader Hussein Submission deadline: 24 June 2024 |
“The Study of Cancer Susceptibility Genes (Volume II)” Edited by Prof. Dr. Youri I. Pavlov Submission deadline: 25 June 2024 |
![]() |
![]() |
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office